Buy Reaferon-es-Lipint (Interferon alfa-2b) lyophilisate

Reaferon-es-Lipint (Interferon alfa-2b) lyophilisate

63263USD

Description

Features

Reviews

Instructions for Reaferon-es-Lipint (Interferon alfa-2b) lyophilisate

Reaferon-es-Lipint (Interferon alfa-2b) lyophilisate

lyophilizate d/ingestion 250 thousand IU suspension fit: fl. 1, 3, 5, 6,10 or 12 pcs
lyophilizate d/ingestion 500 thousand IU suspension fit: fl. 1, 3, 5, 6,10 or 12 pcs

Description
Lyophilizate for preparing a suspension for absorption in the form of a powder or a porous mass in a white or yellowish colour; it is allowed to be peeled away, in whole or in part, from the surface of the glass of the bottle to form a tablet-like shape, hygroscopic.

human recombinant interferon alpha-2b 1 million ME
Auxiliary substances: sodium chloride - 8.01 mg, sodium hydrophosphate dodecahydrate - 4.52 mg, sodium dihydrophosphate dihydrate - 0.56 mg, lipoid C100 (phospholipids (mixture with phosphatidylcholine content not less than 94%) - 41.18 mg, cholesterol - 4.53 mg, α-tocopherol acetate - 0.56 mg, lactose monohydrate - 91.34 mg.

ATC codes
L03AB04 Interferon alfa-2a

Clinical-pharmacological groups / Group affiliation
Interferon. Immunomodulating preparation with antiviral action

Active substance
human recombinant interferon alpha-2b

Pharmaco-therapeutic group Reaferon-es-Lipint

MIBP-Cytokin

Best before date
The shelf life is two years.
Not applicable after expiry date.

Pharmacological effect Reaferon-es-Lipint

It also has an anti-viral effect. Interferon alpha-2b is a human recombination agent, which is an active substance in the preparation, and is synthesized by the bacterial cells of the strain.

Escherichia coli SG-20050/pIF16, which have the human interferon alpha-2b gene embedded in their genetic apparatus. It is a protein containing 165 amino acids and is identical in characteristics and properties to human leukocyte interferon alpha-2b.

Testimony Reaferon-es-Lipint

As part of complex therapy:
acute hepatitis B;
chronic hepatitis B in active and inactive replication forms, and chronic hepatitis B complicated by glomerulonephritis;
atopic diseases, allergic rhinoconjunctivitis, bronchial asthma in the course of specific immunotherapy;
urogenital chlamydia infection in adults;
feverish and meningeal forms of tick-borne encephalitis in adults.
Emergency prevention of tick-borne encephalitis in combination with antitick immunoglobulin.
Prevention and treatment of influenza and ARVI in adults and children.

Method of use, course and dosage Reaferon-es-Lipint

It is administered orally.

One to two ml of distilled or cooled boiled water is added to the contents of the bottle immediately prior to use. A homogeneous suspension shall be formed during 1-5 min shaking.
For acute hepatitis B, the drug is taken thirty minutes before eating according to the following pattern:
adults and children of school age - but one million ME twice a day for ten days;
pre-school children (ages 3-7) - 500,000 ME once a day for ten days or after control biochemical blood tests, longer time - until full clinical recovery.

Nosology (ICD codes)